U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advisory Committee on Immunization Practices (ACIP)

CDC Stacks Public Health Publications

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

(93)
(134)
(234)
(272)
(175)
(108)
(133)
(111)
(96)
(79)
(115)
(115)
(125)
(16)
(23)
(16)
(18)
(13)
(17)
(9)
(8)
(15)
(11)
(6)
(10)
(10)
(5)
(10)
(11)
(5)
(8)
(9)
(6)
(9)
(8)
(7)
(6)
(10)
(5)
(6)
(5)
(6)
(6)
(5)
(5)
(6)
(9)
(3)
(8)
(4)
(3)
(2)
(5)
(3)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
0 of 61
(12)
(32)
(108)
(35)
(11)
(1)
(1)
(48)
(48)
(49)
(7)
(1293)
(463)
(7)
0 of 14
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(2)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(6)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(406)
(1)
(1)
(1)
(1)
(1)
(1)
0 of 46
(1)
(1)
(1)
0 of 3
(10)
(5)
(1)
(4)
(2)
(3)
(1)
(5)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(126)
(1)
(146)
(1)
(33)
(66)
(1)
(1)
(62)
(14)
(2)
(3)
(18)
(1)
(4)
(1)
(1)
(1)
(2)
(31)
(2)
(3)
(1)
(1)
(3)
(6)
(1)
(1)
(10)
(1)
(3)
(2)
(2)
(14)
(2)
(2)
(3)
(5)
(2)
(1)
(9)
(3)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(7)
(1)
(10)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(9)
(1)
(1)
(1)
(12)
(1)
(2)
(1)
(3)
(9)
(1)
(6)
(1)
(3)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(11)
(2)
(2)
(4)
(1)
(3)
(13)
(8)
(153)
(106)
(2)
(2)
(1)
(1)
(11)
(2)
(1)
(10)
(2)
(7)
(2)
(1)
(1)
(1)
(7)
(15)
(4)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(20)
(5)
(197)
(44)
(5)
(4)
(1)
(19)
(2)
(2)
(82)
(2)
(257)
(6)
(21)
(2)
(1)
(3)
(1)
(1)
(8)
(1)
(4)
(2)
(1)
(1)
(117)
(7)
(5)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(3)
(35)
(2)
(1)
(16)
(2)
(12)
(1)
(32)
(2)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(2)
(2)
(10)
(2)
(2)
(2)
(3)
(1)
(1)
(2)
(23)
(10)
(3)
(5)
(1)
(1)
(15)
(1)
(3)
(1)
(9)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(1)
(17)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(5)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(9)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(51)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(21)
(3)
(1)
(5)
(1)
(15)
(1)
(56)
(1)
(2)
(5)
(2)
(2)
(1)
(1)
(3)
(5)
(2)
(1)
(15)
(1)
(1)
(2)
(2)
(1)
(3)
(1)
(33)
(2)
(1)
(3)
(2)
(2)
(1)
(19)
(2)
(2)
(4)
(4)
(2)
(1)
(1)
(2)
(5)
(5)
(1)
(1)
(1)
(7)
(9)
(9)
(1)
(1)
(3)
(1)
(26)
(3)
(1)
(2)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(39)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(2)
(3)
(1)
(35)
(1)
(1)
(1)
(7)
(1)
(6)
(2)
(10)
(11)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(165)
(5)
(1)
(1)
(4)
(343)
(1)
(6)
(3)
(76)
(2)
(2)
(1)
(1)
(1)
(2)
(50)
(6)
(4)
(321)
(1)
(1)
(1)
(192)
(1)
(2)
(17)
(3)
(2)
(3)
(3)
(1)
(1)
(1)
(1)
(6)
(6)
(104)
(1)
(69)
(1)
(5)
(2)
(3)
(2)
(1)
(1)
(39)
(1)
(1)
(10)
(1)
(11)
(4)
(25)
(15)
(2)
(1)
(2)
(1)
(3)
(10)
(4)
(15)
(2)
(13)
(2)
(18)
(6)
(2)
(1)
(1)
(2)
(2)
(4)
(172)
(18)
(2)
(1)
(11)
(5)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(12)
(3)
(2)
(4)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(10)
(1)
(4)
(1)
(1)
(31)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(2)
(6)
(1)
(13)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(40)
(1)
(2)
(8)
(1)
(11)
(1)
(1)
(6)
(28)
(1)
(1)
(1)
(2)
(1)
(7)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(2)
(4)
(1)
(1)
(3)
(14)
(3)
(1)
(10)
(2)
(1)
(104)
(1)
(1)
(1)
(1)
(1)
(1)
(61)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(3)
(4)
(14)
(1)
(12)
(3)
(4)
(3)
(1)
(6)
(1)
(7)
(1)
(1)
(5)
(1)
(13)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(4)
(1)
(7)
(1)
(3)
(6)
(2)
(1)
(2)
(1)
(2)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(29)
(152)
(5)
(1)
(1)
(1)
(3)
(2)
(55)
(1)
(1)
(34)
(1)
(8)
(1)
(1)
(56)
(2)
(1)
(6)
(1)
(1)
(1)
(35)
(2)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(17)
(1)
(1)
(8)
(1)
(91)
(3)
(1)
(2)
(4)
(1)
(1)
(11)
(2)
(3)
(1)
(3)
(1)
(4)
(2)
(6)
(2)
(2)
(1)
(8)
(2)
(1)
(5)
(1)
(10)
(12)
(1)
(6)
(1)
(1)
(1)
(6)
(1)
(35)
(1)
(9)
(1)
(62)
(6)
(3)
(2)
(1)
(1)
(1)
(2)
(1)
(26)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(16)
(1)
(1)
(1)
(4)
(2)
(14)
(1)
(1)
(4)
(3)
(2)
(12)
(1)
(1)
(4)
(5)
(2)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(10)
(6)
(2)
(1)
(49)
(13)
(8)
(48)
(8)
(2)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(18)
(12)
(1)
(1)
(3)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(32)
(5)
(2)
(13)
(5)
(1)
(1)
(2)
(19)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(3)
(2)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(26)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(2)
(1)
(2)
(1)
(3)
(2)
(6)
(1)
(5)
(4)
(8)
(5)
(1)
(1)
(21)
(1)
(1)
(2)
(7)
(3)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(630)
(17)
(2)
(1)
(1)
(5)
(1)
(1)
(24)
(22)
(4)
(4)
(1)
(13)
(379)
(1)
(28)
(23)
(23)
(1)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(2)
(1)
(1)
(51)
(2)
(1)
(11)
(1)
(1)
(18)
(1)
(2)
(1)
(2)
(5)
(3)
(1)
(1)
(12)
(1)
(2)
(170)
(2)
(1)
(1)
(1)
(1)
(21)
(1)
(1)
(10)
(1)
(1)
(4)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(2)
(1)
(11)
(2)
(1)
(2)
(1)
(2)
(1)
(2)
(1)
(33)
(1)
(2)
(4)
0 of 940
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(39)
(2)
(1)
(8)
(16)
(1)
(4)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(2)
(1)
(1)
(3)
(23)
(1)
(1)
(8)
(2)
(1)
(11)
(1)
(1)
(1)
(15)
(1)
(1)
(14)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(8)
(21)
(1)
(1)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(16)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(2)
(7)
(1)
(1)
(5)
(1)
(8)
(2)
(5)
(10)
(2)
(1)
(1)
(2)
(2)
(2)
(22)
(3)
(4)
(4)
(4)
(3)
(1)
(22)
(1)
(7)
(1)
(4)
(2)
(2)
(4)
(4)
(2)
(32)
(2)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(31)
(3)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(7)
(1)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(2)
(2)
(3)
(1)
(7)
(1)
(2)
(1)
(1)
(10)
(10)
(1)
(11)
(2)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(9)
(4)
(2)
(1)
(1)
(1)
(5)
(8)
(1)
(2)
(1)
(5)
(7)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(12)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(51)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(15)
(1)
(4)
(8)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(7)
(1)
(3)
(3)
(1)
(4)
(4)
(1)
(1)
(3)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(20)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(12)
(1)
(1)
(1)
(1)
(9)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(11)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(21)
(1)
(2)
(1)
(3)
(7)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(34)
(2)
(1)
(2)
(8)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(1)
(5)
(1)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(14)
(9)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(37)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(4)
(2)
(10)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(3)
(2)
(2)
(1)
(1)
(4)
(6)
(8)
(1)
(6)
(1)
(2)
(1)
(3)
(5)
(2)
(4)
(2)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(11)
(2)
(1)
(3)
(1)
(4)
(2)
(1)
(12)
(2)
(2)
(6)
(1)
(1)
(9)
(2)
(1)
(2)
(1)
(7)
(7)
(1)
(1)
(2)
(1)
(11)
(8)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(3)
(54)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(6)
(9)
(3)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(1)
(4)
(1)
(3)
(1)
(1)
(6)
(3)
(2)
(2)
(1)
(1)
(1)
(4)
(7)
(2)
(4)
(1)
(8)
(1)
(1)
(25)
(1)
(1)
(10)
(17)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(14)
(4)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(18)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(10)
(1)
(1)
(1)
(1)
(30)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(3)
(1)
(2)
(1)
(19)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(30)
(5)
(1)
(11)
(3)
(1)
(1)
(2)
(1)
(2)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(2)
(1)
(4)
(2)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(2)
(45)
(1)
(1)
(7)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(10)
(1)
(1)
(1)
(10)
(1)
(1)
(13)
(1)
(8)
(7)
(1)
(2)
(1)
(8)
(8)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(7)
(8)
(2)
(1)
(32)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(1)
(2)
(1)
(3)
(5)
(4)
(1)
(2)
(2)
(1)
(1)
(9)
(2)
(2)
(10)
(1)
(1)
(1)
(2)
(1)
(5)
(1)
(1)
(4)
(2)
(2)
(26)
(1)
(1)
(24)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(4)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(5)
(4)
(2)
(2)
(1)
(1)
(11)
(3)
(1)
(4)
(1)
(1)
(5)
(1)
(2)
(9)
(1)
(1)
(6)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 899
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(5)
(24)
(3)
(4)
(6)
(1)
(16)
(21)
(9)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(8)
(1)
(3)
(6)
(1)
(1)
(2)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(29)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(50)
(113)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(5)
(1)
(11)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(8)
(1)
(2)
(7)
(5)
(1)
(1)
(5)
(2)
(6)
(1)
(1)
(1)
(12)
(1)
(9)
(2)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(3)
(4)
(1)
(16)
(11)
(1)
(8)
(6)
(1)
(3)
(1)
(5)
(1)
(3)
(25)
(3)
(8)
(1)
(1)
(1)
(30)
(4)
(6)
(1)
(12)
(34)
(30)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(10)
(14)
(2)
(10)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(46)
(4)
(3)
(2)
(66)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(83)
(1)
(1)
(1)
(2)
(53)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(6)
(9)
(1)
(10)
(1)
(1)
(2)
(3)
(6)
(2)
(1)
(5)
(4)
(1)
(3)
(2)
(1)
(1)
(13)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(22)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(4)
(9)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(3)
(1)
(2)
(10)
(1)
(6)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(3)
(1)
(7)
(1)
(1)
(1)
(1)
(1)
(13)
(1)
(14)
(547)
(1)
(1)
(1)
(6)
(1)
(3)
(1)
(4)
(10)
(1)
(15)
(11)
(14)
(1)
(4)
(4)
(1)
(2)
(2)
(5)
(1)
(4)
(1)
(162)
(1)
(5)
(1)
(3)
(7)
(3)
(1)
(33)
(2)
(14)
(3)
(3)
(9)
(2)
(1)
(10)
(1)
(2)
(30)
(6)
(1)
(4)
(4)
(5)
(2)
(7)
(1)
(6)
(2)
(1)
(19)
(15)
(1)
(1)
(9)
(5)
(1)
(2)
(2)
(18)
(3)
(5)
(46)
(2)
(1)
(2)
(3)
(2)
(1)
(3)
(4)
(1)
(5)
(1)
(1)
(4)
(3)
(1)
(1)
(7)
(2)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
0 of 464
(1)
(74)
(1)
(1)
(1624)
(32)
(7)
(8)
(1)
(14)
(102)
(200)
(10)
(12)
(32)
(1295)
(1)
(18)
(2)
(2)
(38)
(1)
(1)
(1)
0 of 24
(1)
(1)
(1)
(1)
(1)
(1)
0 of 6
(1)
0 of 1
Showing 1541 - 1560 of 2154 results
  • LAIV vs IIV comparative safety studies in children
    LAIV vs. IIV comparative safety studies in children
    Walter, Emmanuel B.
    February 26, 2014 | ACIP: Influenza
    No Description
  • Update on effectiveness and impact of PCV13 use among US children
    Update on effectiveness and impact of PCV13 use among U.S. children
    Moore, Matthew R.
    February 26, 2014 | ACIP: Pneumococcal
    No Description
  • Advisory Committee on Immunization Practices ACIP February 2627 2014 welcome introductions
    Advisory Committee on Immunization Practices (ACIP), February 26-27, 2014 : welcome & introductions
    Temte, Jonathan L. ;
    Pickering, Larry K.
    February 26, 2014 | ACIP: Meeting Agenda, Minutes, etc.
    No Description
  • LAIV supply update
    LAIV supply update
    Coelingh, Kathleen
    February 26, 2014 | ACIP: Influenza
    No Description
  • Interim influenza vaccine safety update liveattenuated and inactivated influenza vaccine in persons 18 years of age US 20132014
    Interim influenza vaccine safety update: live-attenuated and inactivated influenza vaccine in persons <18 years of age, US, 2013-2014
    Cano, Maria
    February 26, 2014 | ACIP: Influenza
    No Description
  • Recommended adult immunization schedule United States 2014
    Recommended adult immunization schedule -- United States, 2014
    United States. Advisory Committee on Immunization Practices.  ...
    February 3, 2014
    The 2014 ACIP Adult Immunization Schedule was approved by the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP), American Academy of Family Physicians (AAFP), the American College of Physicians (ACP), the American College of Obstetricians and Gynecologists (ACOG), and the American College of Nurs ...
    Superseded Public Domain
  • TwoDose Varicella Vaccination Coverage Among Children Aged 7 years Six Sentinel Sites United States 20062012
    Two-Dose Varicella Vaccination Coverage Among Children Aged 7 years — Six Sentinel Sites, United States, 2006–2012
    Lopez, Adriana S. ;
    Cardemil, Cristina
    Feb 28 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    In 2007, the Advisory Committee on Immunization Practices (ACIP) recommended a routine second dose of varicella vaccine for children at age 4-6 years, in addition to the first dose given at age 12-15 months. One strategy recommended for increasing varicella vaccination coverage is a school entry requirement of proof of varicella immunity. To determ ...
    Supporting Files Public Domain
  • Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older United States 2014
    Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
    Bridges, Carolyn B. ;
    Coyne-Beasley, Tamera
    Feb 07 2014 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    Vaccines are recommended for adults on the basis of their age, prior vaccinations, health conditions, lifestyle, occupation, and travel. Reasons for current low levels of vaccination coverage for adult vaccines are multifactorial and include limited awareness among the public about vaccines for adults and gaps in incorporation of regular assessment ...
    Supporting Files Public Domain
  • Advisory Committee on Immunization Practices ACIP summary report October 2334 2013 Atlanta Georgia
    Advisory Committee on Immunization Practices (ACIP) summary report : October 23-34, 2013, Atlanta, Georgia
    United States. Advisory Committee on Immunization Practices.
    Feb. 2014 | ACIP: Meeting Agenda, Minutes, etc.
    2013_10 minutes.pdf
    Public Domain
  • Recommended immunization schedules for persons aged 0 through 18 years United States 2014
    Recommended immunization schedules for persons aged 0 through 18 years United States, 2014
    United States. Advisory Committee on Immunization Practices.  ...
    January 1, 2014
    This schedule includes recommendations in effect as of January 1, 2014. Any dose not administered at the recommended age should be administered at a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred over separate injections of its equivalent component vaccines. Vaccination providers should consul ...
    Superseded Public Domain
  • Use of Japanese encephalitis vaccine in children recommendations of the Advisory Committee on Immunization Practices 2013
    Use of Japanese encephalitis vaccine in children : recommendations of the Advisory Committee on Immunization Practices, 2013
    Bocchini, Joseph A. ;
    Rubin, Lorry
    November 15, 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include children aged 2 months through 16 years. The ACIP JE Vaccine Workgroup reviewed the epidemiology of J ...
    Current Public Domain
  • Use of Japanese Encephalitis Vaccine in Children Recommendations of the Advisory Committee on Immunization Practices 2013
    Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
    Bocchini, Joseph A. ;
    Rubin, Lorry
    Nov 15 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
    On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include children aged 2 months through 16 years. The ACIP JE Vaccine Workgroup reviewed the epidemiology of J ...
    Supporting Files Public Domain
  • Handbook for developing evidencebased recommendations Version 12
    Handbook for developing evidence-based recommendations. Version 1.2
    Ahmed, Faruque.
    November 1, 2013
    The U.S. Advisory Committee on Immunization Practices (ACIP) provides expert external advice and guidance to the Director of the Centers for Disease Control and Prevention (CDC) and the Secretary of the Department of Health and Human Services (HHS) on use of vaccines and related agents for control of vaccine-preventable disease in the U.S. civilian ...
    Public Domain
  • Influenza Workgroup introduction
    Influenza Workgroup introduction
    Karron, Ruth A.
    October 24, 2013 | ACIP: Influenza
    No Description
    Public Domain
  • HPV vaccine updated ACIP statement
    HPV vaccine : updated ACIP statement
    Markowitz, Lauri E.
    October 24, 2013 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
  • Influenza activity update
    Influenza activity update
    Grohskopf, Lisa A.
    October 24, 2013 | ACIP: Influenza
    No Description
    Public Domain
  • Influenza vaccination distribution and coverage United States 201213 season
    Influenza vaccination distribution and coverage, United States, 2012-13 season
    Singleton, James A. ;
    Kennedy, Erin D.
    October 24, 2013 | ACIP: Influenza
    No Description
    Public Domain
  • Plans to evaluate recommendations for booster doses of yellow fever vaccine
    Plans to evaluate recommendations for booster doses of yellow fever vaccine
    Bocchini, Joseph A.
    October 24, 2013 | ACIP: Yellow Fever
    No Description
    Public Domain
  • Fluzone highdose vaccine FIM12 efficacy trial summary results
    Fluzone® high-dose vaccine FIM12 efficacy trial summary results
    Greenberg, David
    October 24, 2013 | ACIP: Influenza
    No Description
    Public Domain
  • Update on HPV vaccination coverage in the US
    Update on HPV vaccination coverage in the US
    Stokley, Shannon
    October 24, 2013 | ACIP: Human Papillomavirus (HPV)
    No Description
    Public Domain
1541 - 1560 / 2154